Method of orally treating inflammatory skin conditions with...

Details Method of orally treating inflammatory skin conditions with... Method of orally treating inflammatory skin conditions with...

2006-04-11

2006-04-11

Wilson, James O. (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S049000, C514S283000, C514S274000, C514S027000, C514S251000, C514S252020, C514S024000, C514S034000, C514S256000, C514S300000, C514S04400A, C514S302000, C514S403000, C536S024500, C536S023100, C536S024310, C536S024330, C536S024100, C536S024300, C536S023200, C435S375000, C435S377000, C435S091100, C435S006120, C435S328000, C435S366000, C435S320100, C435S091300, C435S325000, C424S093210, C424S155100

Reexamination Certificate

active

07026301

ABSTRACT:
The present invention relates to the treatment of inflammatory skin conditions, including psoriasis, with a prodrug of 5-fluorouracil. The invention relates to methods for treatment of psoriasis with capecitabine, an oral prodrug of 5-fluorouracil.

REFERENCES:
patent: 5654286 (1997-08-01), Hostetler
patent: 5922714 (1999-07-01), Hausheer
patent: 6297223 (2001-10-01), Spector et al.
patent: 6664242 (2003-12-01), Bissery

Affiliated with

Also associated with

Rating

Method of orally treating inflammatory skin conditions with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of orally treating inflammatory skin conditions with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of orally treating inflammatory skin conditions with... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3586593